S P van Mens1, T Ten Doesschate2, M F Q Kluytmans-van den Bergh3, J W Mouton4, J W A Rossen5, C Verhulst6, M J M Bonten7, J A J W Kluytmans8. 1. University Medical Center Utrecht, Utrecht University; Department of Medical Microbiology, Utrecht, the Netherlands (currently Maastricht University Medical Center, Maastricht, the Netherlands). 2. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3508 AB, Utrecht, the Netherlands. Electronic address: t.tendoesschate@umcutrecht.nl. 3. Amphia Academy Infectious Disease Foundation, Amphia Hospital, Breda, the Netherlands; Department of Infection Control, Amphia Hospital, Breda, the Netherlands and Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. 4. University of Rotterdam, Erasmus Medical Center, Rotterdam, the Netherlands. 5. University of Groningen, University Medical Center Groningen, Department of Medical Microbiology, Groningen, the Netherlands. 6. Microvida Laboratory for Microbiology, Amphia Hospital, Breda, the Netherlands. 7. University Medical Center Utrecht, Utrecht University; Department of Medical Microbiology; Julius Centre for Health Sciences and Primary Care, Utrecht, the Netherlands. 8. Microvida Laboratory for Microbiology, Amphia Hospital, Breda, the Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Abstract
OBJECTIVES: The increasing use of fosfomycin requires reliable susceptibility testing in clinical practice. The reference standard, agar dilution (AD), is rarely used in routine settings. The fosfomycin Etest (BioMérieux) is frequently used, although reading MICs can be hampered by the interpretation of the growth of macrocolonies in the inhibition zone. We investigated the interobserver (IO), interlaboratory (IL), and interobserver-interlaboratory (IOIL) agreement of the fosfomycin Etest and evaluated the agreement with AD. METHODS: Etests were performed for 57 extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae of four bacterial species (Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca and Enterobacter cloacae) in two laboratories. Photographs of fosfomycin Etests were interpreted by four observers following manufacturer's instructions. RESULTS: Essential agreement (EA) and categorical agreement (CA) between Etest and AD were 57% and 89% (κ-value 0.68), respectively, with an underestimation of Etest interpretations compared with AD of 0.26 (95% confidence interval [CI] 0.03-0.48) 2-fold dilutions. Between Etest observations, IO-EA and -CA were reached in 82% and 94% of comparisons; IL-EA and -CA in 38% and 85% of comparisons; and IOIL-EA and -CA in 40% and 85% of comparisons, respectively. Agreement of the Etest with AD and between Etests was better for E. coli than for other species. Ignoring all macrocolonies and haze during Etest interpretation improved the agreement with AD (CA κ-value 0.80) and between Etests (CA κ-value from 0.68 to 0.81). CONCLUSIONS: In this study on 57 ESBL-producing Enterobacteriaceae, IOIL agreement was low with an EA of 40% and a CA of 85%, affected most by IL agreement and to a lesser extent by IO agreement.
OBJECTIVES: The increasing use of fosfomycin requires reliable susceptibility testing in clinical practice. The reference standard, agar dilution (AD), is rarely used in routine settings. The fosfomycin Etest (BioMérieux) is frequently used, although reading MICs can be hampered by the interpretation of the growth of macrocolonies in the inhibition zone. We investigated the interobserver (IO), interlaboratory (IL), and interobserver-interlaboratory (IOIL) agreement of the fosfomycin Etest and evaluated the agreement with AD. METHODS: Etests were performed for 57 extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae of four bacterial species (Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca and Enterobacter cloacae) in two laboratories. Photographs of fosfomycin Etests were interpreted by four observers following manufacturer's instructions. RESULTS: Essential agreement (EA) and categorical agreement (CA) between Etest and AD were 57% and 89% (κ-value 0.68), respectively, with an underestimation of Etest interpretations compared with AD of 0.26 (95% confidence interval [CI] 0.03-0.48) 2-fold dilutions. Between Etest observations, IO-EA and -CA were reached in 82% and 94% of comparisons; IL-EA and -CA in 38% and 85% of comparisons; and IOIL-EA and -CA in 40% and 85% of comparisons, respectively. Agreement of the Etest with AD and between Etests was better for E. coli than for other species. Ignoring all macrocolonies and haze during Etest interpretation improved the agreement with AD (CA κ-value 0.80) and between Etests (CA κ-value from 0.68 to 0.81). CONCLUSIONS: In this study on 57 ESBL-producing Enterobacteriaceae, IOIL agreement was low with an EA of 40% and a CA of 85%, affected most by IL agreement and to a lesser extent by IO agreement.
Authors: James A Karlowsky; Melanie R Baxter; Alyssa R Golden; Heather J Adam; Andrew Walkty; Philippe R S Lagacé-Wiens; George G Zhanel Journal: J Clin Microbiol Date: 2021-09-08 Impact factor: 5.948
Authors: A Goer; L S Blanchard; A Van Belkum; K J Loftus; T P Armstrong; S G Gatermann; D Shortridge; B J Olson; J K Meece; T R Fritsche; M Pompilio; D Halimi; C Franceschi Journal: J Clin Microbiol Date: 2022-06-23 Impact factor: 11.677
Authors: James A Karlowsky; Philippe R S Lagacé-Wiens; Nancy M Laing; Melanie R Baxter; Heather J Adam; George G Zhanel Journal: J Clin Microbiol Date: 2020-09-22 Impact factor: 5.948
Authors: Iain J Abbott; Elke van Gorp; Rixt A Wijma; Joseph Meletiadis; Jason A Roberts; Johan W Mouton; Anton Y Peleg Journal: Antimicrob Agents Chemother Date: 2020-02-21 Impact factor: 5.191